Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of SEER Registry.
Publication date: Mar 21, 2020 Acral lentiginous melanoma (ALM) is one of the four major ...
Melanoma
This magazine is directed toward patients with Melanoma, their families, care givers, physicians and researchers. The content is gathered, validated, categorized, and supplied using a novel big data cyberinfrastructure technology that continually learns about Melanoma.
You may filter the results to view only the latest news, media (podcasts and videos) or scientific literature using these buttons.
Warning: A non-numeric value encountered in /charisma/scoutCms/magazines/ingentium/wp-content/themes/binderpro/module-magazine.php on line 38
-
-
Amino Acids Sequence Based Analysis of Arginine Deiminase from Different Prokaryotic Organisms: An In silico Approach.
Publication date: Mar 24, 2020 Arginine deiminase is a bacterial enzyme which degrades L-arginine. Some ... -
The Solo Play of TERT Promoter Mutations.
Publication date: Mar 19, 2020 The reactivation of telomerase reverse transcriptase (TERT) protein is the ... -
Management of Malignant Vulval Melanoma: A Retrospective Case Series and Review of the Literature.
Publication date: Mar 20, 2020 The aims of the study were to evaluate clinicopathologic features, ... -
Clinicians’ attitudes to oncology clinical practice guidelines and the barriers and facilitators to adherence: a mixed methods study protocol.
Publication date: Mar 23, 2020 Clinical practice guidelines (CPGs) are designed to reduce inappropriate clinical ... -
Enhanced immunogenicity of mitochondrial-localized proteins in cancer cells.
Publication date: Mar 23, 2020 Epitopes derived from mutated cancer proteins elicit strong antitumor T-cell ... -
A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma.
Publication date: Mar 23, 2020 Preclinical data suggests radiotherapy is beneficial in combination with immune ... -
CXCL-10: a new candidate for melanoma therapy?
Publication date: Mar 23, 2020 Melanoma is a malignancy that stems from melanocytes and is ... -
Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4.
Publication date: Mar 23, 2020 To compare the prognostic value of imaging biomarkers derived from ... -
Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: a pilot study.
Publication date: Mar 24, 2020 Circulating tumour cells (CTCs) from liquid biopsies provide an exceptional ... -
The New Coronavirus (COVID-19): Guidelines for People Coping with Cancer
Publication date: Mar 30, 2020 – Overview & Definition of Coronavirus (COVID-19) – What are ... -
The New Coronavirus (COVID-19): Guidelines for People Coping with Cancer
Publication date: Mar 30, 2020 – Overview & Definition of Coronavirus (COVID-19) – What are ... -
AIM2 inflammasome contributes to brain injury and chronic post-stroke cognitive impairment in mice.
Publication date: Mar 19, 2020 Although over one-third of stroke patients may develop post-stroke cognitive ... -
TERT and TERT promoter in melanocytic neoplasms: current concepts in pathogenesis, diagnosis, and prognosis.
Publication date: Mar 23, 2020 Located on chromosome locus 5p15.33, telomerase reverse transcriptase (TERT or ... -
Dr. Polsky on the Clinical Validity of ctDNA in BRAF-Mutant Melanoma
Publication date: Mar 23, 2020 David Polsky, MD, PhD, the Alfred W. Kopf, MD, Professor ... -
Dr. Polsky on the Clinical Validity of ctDNA in BRAF-Mutant Melanoma
Publication date: Mar 23, 2020 David Polsky, MD, PhD, the Alfred W. Kopf, MD, Professor ... -
Synthesis and evaluation of anti-tumor activity of novel triazolo[1,5-a] pyrimidine on cancer cells by induction of cellular apoptosis and inhibition of epithelial-to-mesenchymal transition process.
Publication date: Mar 17, 2020 Cancer is a leading cause of human death worldwide. One ... -
Dermatoscopic predictors to discriminate between in situ and early invasive lentigo maligna melanoma: A retrospective observational study.
Publication date: Mar 18, 2020 Bagolini, L.P., Apalla, Z., Cuevas, R.G., Lallas, K., Papageorgiou, C., ... -
Adverse events, need for hospitalization and systemic immunosuppression in very older patients (over 80 years) treated with anti-PD-1 for metastatic melanoma.
Publication date: Mar 18, 2020 Open Access PDF Barailler, H., Salomon, G., Dutriaux, C., Prey, ... -
Role of immune checkpoint inhibitors in the revolutionization of advanced melanoma care.
Publication date: Mar 19, 2020 Melanoma cancer is an important public health concern owing to ... -
Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls.
Publication date: Mar 21, 2020 While immune checkpoint inhibitor (ICI) therapy has improved melanoma patient ...